Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern

INTRODUCTION: The aim of this study was to evaluate the risk of hospitalization or death in patients infected by SARS-CoV2 variants of concern (VOCs) receiving combinations of monoclonal antibodies (mAbs), bamlanivimab/etesevimab or casirivimab/imdevimab. METHODS: Observational prospective study con...

Descripción completa

Detalles Bibliográficos
Autores principales: Falcone, Marco, Tiseo, Giusy, Valoriani, Beatrice, Barbieri, Chiara, Occhineri, Sara, Mazzetti, Paola, Vatteroni, Maria Linda, Suardi, Lorenzo Roberto, Riccardi, Niccolò, Pistello, Mauro, Tacconi, Danilo, Menichetti, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386337/
https://www.ncbi.nlm.nih.gov/pubmed/34435337
http://dx.doi.org/10.1007/s40121-021-00525-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386337/
https://www.ncbi.nlm.nih.gov/pubmed/34435337
http://dx.doi.org/10.1007/s40121-021-00525-4

Ejemplares similares